Clinical safety of biosimilar recombinant human granulocyte colony-stimulating factors

Authors:

Abstract
(2013). Clinical safety of biosimilar recombinant human granulocyte colony-stimulating factors. Expert Opinion on Drug Safety: Vol. 12, No. 2, pp. 235-246. doi: 10.1517/14740338.2013.770472